Determining how effectively a drug is being absorbed by the human body is a tricky business.
While age and weight can give doctors a good indication, a patients’ metabolism, the foods they eat and other drugs they might be taking can all have an effect on efficacy.
Looking to solve this problem, engineers from the University of California, Santa Barbara have developed an implantable device that provides real time feedback on how much medication is currently in a person’s bloodstream.
While still in the early stages of development, the researchers say the prototype device, called MEDIC (Microfluidic Electrochemical Detector for In vivo Concentrations), could revolutionise the way treatment is given and measured in the future.
Kevin Plaxco, a professor of biomolecular science and engineering, believes it could even be used to deliver drugs automatically, with dosages based on the feedback generated by the device.
An artificial pancreas, which monitors glucose levels in diabetics and uses this information to inject a controlled amount of insulin, is an example of one such system.
The MEDIC device consists of a microfluidic chamber lined with gold electrodes from which drug-recognising biomolecules – in this case artificial DNA strands called aptamers – extend.
When the target molecule comes in contact with an aptamer, the strand recognises it and wraps around the molecule, delivering electrons from its tip to the electrode at the aptamer’s base. The tiny jolt of current signals the presence of the molecule.
Because previous iterations of the device failed within half an hour – due to the components in whole blood clinging to the sensors – the researchers decided to introduce a second flow into the chamber.
This acted like a filter, separating the large blood components from the small drug molecules.
In tests, the researchers found they could easily and accurately measure the effectiveness of a particular drug in the bloodstream, even when a cocktail of drugs was administered.
The Latest on: Drug levels in the bloodstream
via Google News
The Latest on: Drug levels in the bloodstream
- Injectable Drugs for Type-2 Diabetes Market- Global Demand Analysis, Emerging Trends, Technological Innovations & Opportunity Outlook 2028on January 27, 2021 at 4:58 am
Research Nester published a report titled "Injectable Drugs for Type-2 Diabetes Market: Global Demand Analysis ...
- Gut Microbiota Composition Indicates Efficacy of Drugs in Inflammatory Bowel Diseaseson January 27, 2021 at 2:04 am
Researchers investigated whether any predictors associated with infliximab therapy could be identified in the gut microbiota.
- Drug-Impaired Doctor Sentenced to 20 Years for Manslaughteron January 26, 2021 at 3:00 pm
A pathologist who misdiagnosed or made errors for more than 3000 patients while intoxicated has been sentenced to 20 years in prison for manslaughter and mail fraud.
- International team of scientists identifies new treatment for COVID-19 that appears to be far more effective than drugs in use nowon January 25, 2021 at 8:20 pm
Instead of randomly testing existing drugs or targeting key proteins in the virus, the team focused on human proteins needed by the virus.
- Moderna shot protects against new virus variants; higher blood thinner dose keeps patients off ventilatorson January 25, 2021 at 4:45 pm
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
- The Alzheimer's Drugs Showing Early Promiseon January 22, 2021 at 3:08 pm
A small study has found that the experimental drug donanemab may slow cognitive decline in Alzheimer's patients. It joins others that show promise.
- Blood Cancer Drugs Market Size 2020 Analysis and In-depth Research on Trends, Emerging Growth Factors and Forecast to 2024on January 22, 2021 at 5:59 am
Jan (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Blood cancers, or hematologic ...
- New Safety Concern for Migraine Drug?on January 20, 2021 at 3:32 pm
Erenumab, the first in a relatively new class of drugs approved for migraine prevention, is a monoclonal antibody designed to block the calcitonin gene-related peptide (CGRP) receptor. CGRP is a ...
- Ceracare Supplement Reviews – CeraCare Advanced Blood Sugar Support Facts Revealed by Liver Philon January 20, 2021 at 2:32 pm
Brand Partner Content by KISS PR Brand Story* High blood sugar and diabetes are menaces that are threatening millions of people worldwide. About 1.6 million deaths are attributed to diabetes every ...
- Two common blood pressure drugs are not tied to increased risk of COVID-19on January 18, 2021 at 3:51 pm
Research published in the peer-reviewed journal The Lancet Digital Health and co-led by a UCLA Fielding School of Public Health faculty member has found that two widely used types of blood pressure ...
via Bing News